BioMarin Pharmaceutical Inc. (BMRN)
USD 60.58
(-10.23%)
USD 60.58
(-10.23%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 593.09 Million USD | -45.24% |
| 2022 | 1.08 Billion USD | 0.37% |
| 2021 | 1.07 Billion USD | 0.37% |
| 2020 | 1.07 Billion USD | 121.11% |
| 2019 | 486.23 Million USD | -41.45% |
| 2018 | 830.41 Million USD | 2.08% |
| 2017 | 813.52 Million USD | 23.12% |
| 2016 | 660.76 Million USD | -0.23% |
| 2015 | 662.28 Million USD | 0.66% |
| 2014 | 657.97 Million USD | 0.37% |
| 2013 | 655.56 Million USD | 101.8% |
| 2012 | 324.85 Million USD | -6.74% |
| 2011 | 348.32 Million USD | -7.73% |
| 2010 | 377.52 Million USD | -24.05% |
| 2009 | 497.08 Million USD | 0.0% |
| 2008 | 497.08 Million USD | -0.06% |
| 2007 | 497.37 Million USD | 122.1% |
| 2006 | 223.94 Million USD | 5.17% |
| 2005 | 212.92 Million USD | -6.63% |
| 2004 | 228.03 Million USD | 82.43% |
| 2003 | 125 Million USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 3.96 Million USD | 6973.21% |
| 2000 | 56 Thousand USD | -34.12% |
| 1999 | 85 Thousand USD | -15.0% |
| 1998 | 100 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 593.6 Million USD | 0.09% |
| 2024 Q3 | 594.62 Billion USD | 0.09% |
| 2024 Q2 | 594.11 Million USD | 0.09% |
| 2023 Q4 | 593.09 Million USD | 0.09% |
| 2023 Q3 | 592.58 Million USD | -45.38% |
| 2023 FY | 593.09 Million USD | -45.24% |
| 2023 Q2 | 1.08 Billion USD | 0.09% |
| 2023 Q1 | 1.08 Billion USD | 0.09% |
| 2022 Q4 | 1.08 Billion USD | 0.09% |
| 2022 Q1 | 1.08 Billion USD | 0.09% |
| 2022 Q3 | 1.08 Billion USD | 0.09% |
| 2022 Q2 | 1.08 Billion USD | 0.09% |
| 2022 FY | 1.08 Billion USD | 0.37% |
| 2021 Q2 | 1.07 Billion USD | 0.09% |
| 2021 Q1 | 1.07 Billion USD | 0.09% |
| 2021 Q4 | 1.07 Billion USD | 0.09% |
| 2021 FY | 1.07 Billion USD | 0.37% |
| 2021 Q3 | 1.07 Billion USD | 0.09% |
| 2020 Q2 | 1.07 Billion USD | 120.5% |
| 2020 Q1 | 486.71 Million USD | 0.1% |
| 2020 Q3 | 1.07 Billion USD | 0.09% |
| 2020 FY | 1.07 Billion USD | 121.11% |
| 2020 Q4 | 1.07 Billion USD | 0.09% |
| 2019 Q4 | 486.23 Million USD | -42.36% |
| 2019 FY | 486.23 Million USD | -41.45% |
| 2019 Q1 | 834.76 Million USD | 0.52% |
| 2019 Q2 | 839.16 Million USD | 0.53% |
| 2019 Q3 | 843.61 Million USD | 0.53% |
| 2018 Q3 | 826.11 Million USD | 0.52% |
| 2018 Q1 | 817.67 Million USD | 0.51% |
| 2018 FY | 830.41 Million USD | 2.08% |
| 2018 Q2 | 821.87 Million USD | 0.51% |
| 2018 Q4 | 830.41 Million USD | 0.52% |
| 2017 Q4 | 813.52 Million USD | -30.23% |
| 2017 Q3 | 1.16 Billion USD | 72.44% |
| 2017 Q2 | 676.2 Million USD | 1.16% |
| 2017 Q1 | 668.43 Million USD | 1.16% |
| 2017 FY | 813.52 Million USD | 23.12% |
| 2016 Q1 | 668 Million USD | 0.86% |
| 2016 Q4 | 660.76 Million USD | 1.16% |
| 2016 Q2 | 645.68 Million USD | -3.34% |
| 2016 FY | 660.76 Million USD | -0.23% |
| 2016 Q3 | 653.17 Million USD | 1.16% |
| 2015 Q1 | 655.49 Million USD | -0.38% |
| 2015 FY | 662.28 Million USD | 0.66% |
| 2015 Q4 | 662.28 Million USD | -0.82% |
| 2015 Q2 | 661.49 Million USD | 0.92% |
| 2015 Q3 | 667.79 Million USD | 0.95% |
| 2014 Q4 | 657.97 Million USD | 0.17% |
| 2014 Q2 | 650.87 Million USD | -1.59% |
| 2014 FY | 657.97 Million USD | 0.37% |
| 2014 Q1 | 661.41 Million USD | 0.89% |
| 2014 Q3 | 656.88 Million USD | 0.92% |
| 2013 Q2 | 109.82 Million USD | -0.02% |
| 2013 Q1 | 109.84 Million USD | -66.19% |
| 2013 FY | 655.56 Million USD | 101.8% |
| 2013 Q3 | 78.31 Million USD | -28.69% |
| 2013 Q4 | 655.56 Million USD | 737.14% |
| 2012 Q1 | 324.87 Million USD | -6.73% |
| 2012 FY | 324.85 Million USD | -6.74% |
| 2012 Q4 | 324.85 Million USD | -0.0% |
| 2012 Q3 | 324.86 Million USD | -0.0% |
| 2012 Q2 | 324.86 Million USD | -0.0% |
| 2011 FY | 348.32 Million USD | -7.73% |
| 2011 Q4 | 348.32 Million USD | -0.0% |
| 2011 Q3 | 348.33 Million USD | -7.73% |
| 2011 Q1 | 377.52 Million USD | 0.0% |
| 2011 Q2 | 377.52 Million USD | -0.0% |
| 2010 Q1 | 497.08 Million USD | 0.0% |
| 2010 FY | 377.52 Million USD | -24.05% |
| 2010 Q2 | 497.08 Million USD | 0.0% |
| 2010 Q3 | 497.08 Million USD | 0.0% |
| 2010 Q4 | 377.52 Million USD | -24.05% |
| 2009 Q3 | 497.08 Million USD | 0.0% |
| 2009 FY | 497.08 Million USD | 0.0% |
| 2009 Q1 | 497.08 Million USD | 0.0% |
| 2009 Q2 | 497.08 Million USD | 0.0% |
| 2009 Q4 | 497.08 Million USD | 0.0% |
| 2008 Q3 | 497.24 Million USD | -0.0% |
| 2008 FY | 497.08 Million USD | -0.06% |
| 2008 Q1 | 497.3 Million USD | -0.02% |
| 2008 Q2 | 497.24 Million USD | -0.01% |
| 2008 Q4 | 497.08 Million USD | -0.03% |
| 2007 Q2 | 564.7 Million USD | 134.86% |
| 2007 Q3 | 564.32 Million USD | -0.07% |
| 2007 Q1 | 240.44 Million USD | 7.37% |
| 2007 Q4 | 497.37 Million USD | -11.86% |
| 2007 FY | 497.37 Million USD | 122.1% |
| 2006 FY | 223.94 Million USD | 5.17% |
| 2006 Q3 | 293.08 Million USD | -20.21% |
| 2006 Q2 | 367.31 Million USD | -0.14% |
| 2006 Q1 | 367.83 Million USD | 72.76% |
| 2006 Q4 | 223.94 Million USD | -23.59% |
| 2005 FY | 212.92 Million USD | -6.63% |
| 2005 Q4 | 212.92 Million USD | -0.71% |
| 2005 Q3 | 214.44 Million USD | -0.7% |
| 2005 Q2 | 215.96 Million USD | 49.35% |
| 2005 Q1 | 144.6 Million USD | -36.59% |
| 2004 Q1 | 125 Million USD | 0.0% |
| 2004 FY | 228.03 Million USD | 82.43% |
| 2004 Q4 | 228.03 Million USD | 2.69% |
| 2004 Q3 | 222.06 Million USD | 72.44% |
| 2004 Q2 | 128.77 Million USD | 3.02% |
| 2003 Q3 | 125 Million USD | 0.0% |
| 2003 Q2 | 125 Million USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | 125 Million USD | 0.0% |
| 2003 Q4 | 125 Million USD | 0.0% |
| 2002 Q1 | 3.5 Million USD | -11.56% |
| 2002 Q4 | - USD | -100.0% |
| 2002 FY | - USD | -100.0% |
| 2002 Q2 | - USD | -100.0% |
| 2002 Q3 | 2.91 Million USD | 0.0% |
| 2001 Q1 | 47 Thousand USD | -16.07% |
| 2001 Q2 | 198 Thousand USD | 321.28% |
| 2001 Q3 | 146 Thousand USD | -26.26% |
| 2001 Q4 | 3.96 Million USD | 2613.01% |
| 2001 FY | 3.96 Million USD | 6973.21% |
| 2000 Q1 | 77 Thousand USD | -9.41% |
| 2000 FY | 56 Thousand USD | -34.12% |
| 2000 Q4 | 56 Thousand USD | -11.11% |
| 2000 Q3 | 63 Thousand USD | -7.35% |
| 2000 Q2 | 68 Thousand USD | -11.69% |
| 1999 Q2 | 26.1 Million USD | 26000.0% |
| 1999 Q4 | 85 Thousand USD | -15.0% |
| 1999 FY | 85 Thousand USD | -15.0% |
| 1999 Q3 | 100 Thousand USD | -99.62% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1998 FY | 100 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -732.741% |
| Alkermes plc | 287.73 Million USD | -106.129% |
| Agenus Inc. | 137.32 Million USD | -331.895% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 74.687% |
| Aptorum Group Limited | 3.05 Million USD | -19291.695% |
| Ardelyx, Inc. | 51.54 Million USD | -1050.591% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -466.969% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1379.778% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -489.569% |
| ChromaDex Corporation | 2.57 Million USD | -22932.816% |
| Chimerix, Inc. | 125 Thousand USD | -474376.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -18213.139% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -2189.235% |
| CRISPR Therapeutics AG | 223 Million USD | -165.954% |
| Precision BioSciences, Inc. | 7.72 Million USD | -7579.593% |
| Dyadic International, Inc. | 88.87 Thousand USD | -667273.692% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -2695786.364% |
| Fortress Biotech, Inc. | 60.85 Million USD | -874.588% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -964344.842% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -15503.657% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -657987.746% |
| Incyte Corporation | 29.16 Million USD | -1933.794% |
| IO Biotech, Inc. | 1.83 Million USD | -32150.952% |
| Jaguar Health, Inc. | 30.99 Million USD | -1813.642% |
| Novavax, Inc. | 168.01 Million USD | -252.999% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -2475.874% |
| Opthea Limited | 200.53 Million USD | -195.755% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -10205.734% |
| ContextLogic Inc. | 6 Million USD | -9784.917% |
| MiMedx Group, Inc. | 48.09 Million USD | -1133.071% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -2850.868% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1548814.889% |
| NextCure, Inc. | 5.94 Million USD | -9869.659% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -408931.034% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -2582.353% |
| PDS Biotechnology Corporation | 19.5 Million USD | -2940.549% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -413.591% |
| Pharming Group N.V. | 166.1 Million USD | -257.06% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -9446.033% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -1669.64% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -49078.69% |
| Acelyrin, Inc. | 1.19 Million USD | -49572.948% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -128833.696% |
| Summit Therapeutics Inc. | 103.29 Million USD | -474.204% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -15636.137% |
| Senti Biosciences, Inc. | 33.53 Million USD | -1668.427% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -12326.042% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1616.33% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -883.231% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -37676.752% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -2234.652% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -468.436% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -80923.907% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -5199.75% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -328.834% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -4313.238% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -3853.967% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -210.632% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1026.315% |
| Fortress Biotech, Inc. | 60.85 Million USD | -874.588% |
| Precigen, Inc. | 5.89 Million USD | -9960.984% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1312.535% |
| AlloVir, Inc. | 16.64 Million USD | -3462.56% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -801.95% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -509.177% |
| ImmuCell Corporation | 10.54 Million USD | -5526.822% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -52619.556% |
| Onconetix, Inc. | 118.85 Thousand USD | -498898.797% |
| PureTech Health plc | 18.25 Million USD | -3149.836% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -598985.859% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1867.996% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -2184.297% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1283.344% |
| Innoviva, Inc. | 446.23 Million USD | -32.911% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -71099.88% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -887182.329% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -186.564% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -733.045% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -18503.984% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -57038.247% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -2556.522% |
| Aptose Biosciences Inc. | 621 Thousand USD | -95406.441% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -58568.024% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1171.154% |
| Kura Oncology, Inc. | 9.33 Million USD | -6255.497% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -2121.33% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -429678.986% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -6219.606% |
| Autolus Therapeutics plc | 47.91 Million USD | -1137.832% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -11989.177% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -8656.755% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -353.922% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -7217.643% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1610.588% |
| INmune Bio, Inc. | 397 Thousand USD | -149294.207% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -241.344% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -14528.934% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -403506.013% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1091.624% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -986.852% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1198.0% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -25.292% |
| Verastem, Inc. | 40.08 Million USD | -1379.556% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -13373.308% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -5799.095% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -8939.704% |
| Histogen Inc. | 4.38 Million USD | -13428.627% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -67144.331% |
| Organovo Holdings, Inc. | 888 Thousand USD | -66689.977% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -1876.983% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -14041.512% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -3038.899% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -683.481% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -636924.188% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -2189.323% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -222032.959% |
| Amarin Corporation plc | 8.73 Million USD | -6688.314% |
| Mesoblast Limited | 100.48 Million USD | -490.244% |
| Turnstone Biologics Corp. | 1.18 Million USD | -49781.833% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -657.184% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -544023.853% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -623.207% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -212.247% |
| Better Therapeutics, Inc. | 10.34 Million USD | -5631.494% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -2464.735% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -537.51% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -45805.186% |
| Gritstone bio, Inc. | 40.14 Million USD | -1377.419% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -32595.424% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -286.147% |
| Insmed Incorporated | 1.19 Billion USD | 50.3% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -9240.079% |
| OmniAb, Inc. | 22.07 Million USD | -2586.727% |
| Alector, Inc. | 30.45 Million USD | -1847.383% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -484.077% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -7270.386% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -39.03% |
| Aura Biosciences, Inc. | 16.87 Million USD | -3415.679% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -942.456% |
| Immunic, Inc. | 639 Thousand USD | -92716.119% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -1888.984% |
| Veracyte, Inc. | 7.52 Million USD | -7781.661% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 8.028% |
| FibroGen, Inc. | 89.69 Million USD | -561.221% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -13575.236% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -453118.251% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 88.389% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1602859.459% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -29854.293% |
| TG Therapeutics, Inc. | 100.11 Million USD | -492.396% |
| Galecto, Inc. | 66 Thousand USD | -898528.788% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -435999.265% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 63.667% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -9760.266% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -10889.346% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -32595.424% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -2665.398% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -1522.473% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -114618.569% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1211.113% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -1839.867% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1223.814% |
| Vaxxinity, Inc. | 13.26 Million USD | -4372.138% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 26.893% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -131976.837% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -6648.151% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 78.057% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -187588.291% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -13204.06% |
| Ainos, Inc. | 5.92 Million USD | -9915.864% |
| Pluri Inc. | 29.05 Million USD | -1941.424% |
| Prothena Corporation plc | 10.72 Million USD | -5432.087% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -2887.734% |
| Celularity Inc. | 26.17 Million USD | -2165.71% |
| Rallybio Corporation | 173 Thousand USD | -342729.48% |
| Cue Biopharma, Inc. | 4.2 Million USD | -14014.588% |
| MeiraGTx Holdings plc | 72.11 Million USD | -722.384% |
| Omeros Corporation | 329.7 Million USD | -79.887% |
| Humacyte, Inc. | 38.6 Million USD | -1436.516% |
| Immunocore Holdings plc | 82.64 Million USD | -617.65% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -36669.684% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -16480.794% |
| Blueprint Medicines Corporation | 610.96 Million USD | 2.924% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -40578.669% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -523.071% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1118.254% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -552.463% |
| Pulmatrix, Inc. | 8.32 Million USD | -7022.553% |
| Elicio Therapeutics, Inc. | 6 Million USD | -9773.398% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -4481.653% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -513.037% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -126359.488% |
| Cytokinetics, Incorporated | 607.37 Million USD | 2.351% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -6723.458% |
| Nutriband Inc. | 79.82 Thousand USD | -742884.742% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -13126.918% |
| Vor Biopharma Inc. | 31.83 Million USD | -1763.321% |
| Roivant Sciences Ltd. | 477.85 Million USD | -24.116% |
| Evogene Ltd. | 10.65 Million USD | -5467.399% |
| ProKidney Corp. | 3.61 Million USD | -16329.224% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -78041.634% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -2252786.88% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 65.83% |
| CorMedix Inc. | 517.01 Thousand USD | -114615.684% |
| BioLineRx Ltd. | 6.62 Million USD | -8848.325% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -1510.009% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -726.717% |
| Atai Life Sciences N.V. | 15.21 Million USD | -3799.119% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -70306.309% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -232486.275% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1274.496% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -144324.828% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -43223.229% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -89342.904% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -233.068% |
| Biomea Fusion, Inc. | 7.83 Million USD | -7474.649% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -108.68% |
| Mereo BioPharma Group plc | 5.3 Million USD | -11090.472% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -27485.814% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -100766.497% |
| Absci Corporation | 4.66 Million USD | -12627.361% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -5047.5% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -2513.329% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -5827.986% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -5055.106% |
| Allakos Inc. | 38.21 Million USD | -1451.995% |
| Imunon, Inc. | 1.13 Million USD | -51958.162% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -6773.276% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -70844.378% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -5930850.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -571.332% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -12494.925% |
| XOMA Corporation | 118.51 Million USD | -400.426% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -5790.307% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -1499.544% |
| aTyr Pharma, Inc. | 13.76 Million USD | -4208.092% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -7408.482% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -2275.801% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -2835.387% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -3953866.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -213097.814% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4003.084% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 60.441% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -435445.226% |
| UroGen Pharma Ltd. | 98.55 Million USD | -501.815% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -297.746% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -3010.584% |
| Entera Bio Ltd. | 256 Thousand USD | -231577.734% |
| GH Research PLC | 631 Thousand USD | -93892.868% |
| Lisata Therapeutics, Inc. | 137.00 USD | -432915958.394% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -92282.399% |
| Xencor, Inc. | 14.64 Million USD | -3950.642% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -394636.142% |
| Replimune Group, Inc. | 71.99 Million USD | -723.857% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -395296.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -8365.53% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -435445.226% |
| Portage Biotech Inc. | 7000.00 USD | -8472685.714% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -89342.904% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -41404.199% |
| OncoCyte Corporation | 2.2 Million USD | -26809.936% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -886373.358% |
| Purple Biotech Ltd. | 163 Thousand USD | -363761.963% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -23296.252% |
| scPharmaceuticals Inc. | 38.81 Million USD | -1428.162% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -2249.449% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -812358.904% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -31907.285% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -2151.006% |
| Curis, Inc. | 1.48 Million USD | -39731.766% |
| Daré Bioscience, Inc. | 3.91 Million USD | -15054.423% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -84905.339% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -9884816.667% |
| BeiGene, Ltd. | 197.61 Million USD | -200.122% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -64968.02% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -636.078% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1043.007% |
| bluebird bio, Inc. | 224.41 Million USD | -164.28% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| DBV Technologies S.A. | 4.52 Million USD | -13004.176% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -44160.821% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -5988.021% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -15644.492% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -57.21% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1283.247% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -34442.516% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -63811.099% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -3295.517% |
| MacroGenics, Inc. | 30.19 Million USD | -1864.151% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -3250.251% |
| Prime Medicine, Inc. | 4.35 Million USD | -13512.463% |
| Aditxt, Inc. | 1.04 Million USD | -56832.893% |
| Adagene Inc. | 13.54 Million USD | -4280.307% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4217.5% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -14.341% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -3369.812% |
| SciSparc Ltd. | 24 Thousand USD | -2471129.167% |
| Vericel Corporation | 81.85 Million USD | -624.559% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -623.138% |
| Generation Bio Co. | 89.77 Million USD | -560.653% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -2573.405% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -193.904% |
| Invivyd, Inc. | 722 Thousand USD | -82046.122% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1122.826% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -20285459.884% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -15405.752% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -2578573.913% |
| 2seventy bio, Inc. | 244.01 Million USD | -143.059% |
| ADMA Biologics, Inc. | 130.59 Million USD | -354.152% |
| Clene Inc. | 7.15 Million USD | -8192.715% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -17466.632% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -139.521% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -53768.756% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -225527.223% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -207.909% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -1988.142% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -6053.076% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -431.1% |
| Evaxion Biotech A/S | 8.48 Million USD | -6886.836% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -691.585% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -816.472% |
| Trevena, Inc. | 35.23 Million USD | -1583.351% |
| Surrozen, Inc. | 882 Thousand USD | -67144.331% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -9441.425% |
| Cingulate Inc. | 135.09 Thousand USD | -438907.691% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -2419.627% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1140.785% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -329397.222% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -2236.952% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -3301.359% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -63264.85% |
| Statera Biopharma, Inc. | 11.43 Million USD | -5088.415% |
| ImmunityBio, Inc. | 836.95 Million USD | 29.136% |
| Korro Bio, Inc. | 31.21 Million USD | -1799.971% |
| Kineta, Inc. | 150 Thousand USD | -395296.667% |
| BioVie Inc. | 349.89 Thousand USD | -169407.051% |
| Codexis, Inc. | 12.24 Million USD | -4744.36% |
| Celularity Inc. | 26.17 Million USD | -2165.71% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1147.177% |
| Celcuity Inc. | 37.03 Million USD | -1501.427% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -336226.519% |
| Cibus, Inc. | 17.67 Million USD | -3255.749% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -17452.382% |
| Kodiak Sciences Inc. | 100 Million USD | -493.095% |
| Annexon, Inc. | 29.19 Million USD | -1931.843% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -817.72% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -52760.517% |
| Avalo Therapeutics, Inc. | 2 Million USD | -29554.75% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 57.647% |
| Eyenovia, Inc. | 8.95 Million USD | -6521.41% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -803.296% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -7184.39% |
| Arcellx, Inc. | 50.84 Million USD | -1066.568% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -40578.669% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -2692.612% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -56117.536% |
| Moolec Science SA | 99.04 Thousand USD | -598707.625% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -2047.261% |
| Geron Corporation | 35.05 Million USD | -1592.092% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -100254.484% |
| Royalty Pharma plc | 6.13 Billion USD | 90.333% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -36020.28% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1868386.548% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -2462.187% |
| Humacyte, Inc. | 38.6 Million USD | -1436.516% |
| Structure Therapeutics Inc. | 4.01 Million USD | -14679.342% |
| 89bio, Inc. | 24.79 Million USD | -2291.994% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -4669.945% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -31684.298% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -57370.446% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -496.027% |
| Notable Labs, Ltd. | 1.52 Million USD | -38765.99% |
| Liquidia Corporation | 2.36 Million USD | -24988.621% |
| Mustang Bio, Inc. | 1.97 Million USD | -29884.58% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -4217.5% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -8430.059% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -186996.215% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1089.115% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -6075.5% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -905540.642% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -435999.265% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -9368.311% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -456126.923% |
| PepGen Inc. | 17.1 Million USD | -3368.392% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -125025.527% |
| United Therapeutics Corporation | 300 Million USD | -97.698% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -2377.319% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -14147.324% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -102511.592% |
| XOMA Corporation | 118.51 Million USD | -400.426% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1602859.459% |
| Bionomics Limited | 117.62 Million USD | -404.212% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -63468.596% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -10472.103% |
| uniQure N.V. | 130.06 Million USD | -355.999% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -912.28% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -86356.997% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -13575.236% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -42722.744% |
| Altimmune, Inc. | 175 Thousand USD | -338811.429% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -52.916% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -10472.103% |
| Compugen Ltd. | 719 Thousand USD | -82388.873% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -11607.363% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -601.431% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -5872.759% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -9197.617% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -548.829% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -5872.759% |
| Instil Bio, Inc. | 81.42 Million USD | -628.376% |
| argenx SE | 15.35 Million USD | -3762.804% |
| Immunome, Inc. | 1.34 Million USD | -44160.821% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -110552.052% |
| Verona Pharma plc | 48.37 Million USD | -1126.062% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -6335.493% |
| Shattuck Labs, Inc. | 3.4 Million USD | -17313.241% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -697658.824% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -352932.738% |
| Moolec Science SA | 99.04 Thousand USD | -598707.625% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -5276.101% |
| AnaptysBio, Inc. | 16.03 Million USD | -3598.291% |
| Design Therapeutics, Inc. | 2.33 Million USD | -25311.097% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -2190786.927% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -9784.917% |
| Achilles Therapeutics plc | 1.07 Million USD | -55020.353% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -6335.493% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -2974894.984% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -3442.466% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -742884.742% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -7949169.535% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -4562169.231% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -73.176% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -2322.378% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -23623.895% |
| Palisade Bio, Inc. | 90 Thousand USD | -658894.444% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -305619.072% |
| Beam Therapeutics Inc. | 159.91 Million USD | -270.891% |
| Neurogene Inc. | 13.37 Million USD | -4335.018% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -93.556% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -2158.291% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -991332.918% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -59209.5% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1364.143% |
| Athira Pharma, Inc. | 1.21 Million USD | -48634.182% |
| Vaccinex, Inc. | 26 Thousand USD | -2281034.615% |
| HCW Biologics Inc. | 6.3 Million USD | -9307.758% |
| XOMA Corporation | 118.51 Million USD | -400.426% |
| Nektar Therapeutics | 112.62 Million USD | -426.61% |
| Arvinas, Inc. | 800 Thousand USD | -74036.875% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4003.084% |
| Merus N.V. | 10.48 Million USD | -5554.987% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -3884.515% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -4316.524% |
| Rezolute, Inc. | 1.66 Million USD | -35628.614% |
| Clene Inc. | 7.15 Million USD | -8192.715% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -808504.188% |
| BeyondSpring Inc. | 3.36 Million USD | -17530.648% |
| Synlogic, Inc. | 12.49 Million USD | -4648.179% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -1716.19% |
| Krystal Biotech, Inc. | 6.62 Million USD | -8859.139% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -247.004% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -9791.511% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1251921.279% |
| MannKind Corporation | 252.15 Million USD | -135.214% |
| Ikena Oncology, Inc. | 7.18 Million USD | -8160.376% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -297937.688% |
| Gossamer Bio, Inc. | 197.4 Million USD | -200.446% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -113956.731% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -110.82% |
| Mural Oncology plc | 8.91 Million USD | -6555.763% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -1256.08% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -41201.88% |
| Champions Oncology, Inc. | 6.09 Million USD | -9634.039% |
| REGENXBIO Inc. | 82.22 Million USD | -621.334% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -119958.987% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -13276.071% |
| Vaxart, Inc. | 2.62 Million USD | -22511.323% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -218245.844% |
| Cellectis S.A. | 36.24 Million USD | -1536.53% |
| Longeveron Inc. | 1.44 Million USD | -40859.599% |
| Repare Therapeutics Inc. | 1.01 Million USD | -58622.277% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 47.63% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1224.789% |
| Revolution Medicines, Inc. | 80.57 Million USD | -636.078% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -18387.999% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -334981.921% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -482091.057% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 18.16% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1218.546% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -4643.147% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -438907.691% |
| Passage Bio, Inc. | 22.92 Million USD | -2487.562% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -9721.08% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -91568.47% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -2841.21% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -120939.796% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -145460.145% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -49823.822% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -127173.605% |
| OmniAb, Inc. | 22.07 Million USD | -2586.727% |
| Anew Medical, Inc. | 1.54 Million USD | -38412.662% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -1906.412% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -6465.87% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -1807.671% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -14528.934% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1050.368% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -9215.141% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -4097.714% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -88158.185% |
| Alumis Inc. Common Stock | 30.86 Million USD | -1821.889% |
| Equillium, Inc. | 384 Thousand USD | -154351.823% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -9529.729% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -292.651% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -1113.394% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -492905.104% |
| Dominari Holdings Inc. | 3.02 Million USD | -19487.021% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -2999419.547% |
| vTv Therapeutics Inc. | 169 Thousand USD | -350843.787% |
| Bio-Techne Corporation | 319 Million USD | -85.923% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -940.737% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -232.143% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -3749.516% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -4689.591% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -12238.153% |
| Nkarta, Inc. | 82.27 Million USD | -620.913% |
| BioCardia, Inc. | 982 Thousand USD | -60296.64% |
| Iterum Therapeutics plc | 18.95 Million USD | -3028.798% |